    Yoav Waizer | Medica Venture Partners | ZoomInfo.com      Zvi Yoav Waizer - Insider Monkey                          Companies 0 See All     Hedge Funds 0 See All    Insiders 0 See All    Institutional Investors 0 See All   Click here to see all  results for  Sorry, no results has been found matching your query.                   Adblocker Detected    Dear Valued Visitor, We have noticed that you are using an ad blocker software.
    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login. We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.       Home > Insider Trading > Zvi Yoav Waizer
				> Profile    Zvi Yoav Waizer    Profile Insider Purchases Insider Sales News      Affiliations  Director at Microbot Medical Inc. (MBOT), 2016-11-30                Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map  All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.             

Yoav Zvi Waizer: Executive Profile & Biography - Bloomberg









































  





















































































July 29, 2017 1:54 AM ET
Capital Markets

Company Overview of Medica Venture Partners



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Yoav Zvi Waizer  Partner and Chief Financial Officer, Medica Venture PartnersAgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.See Board Relationships51--
Background

		Mr. Yoav Zvi Waizer is a Partner and Chief Executive Officer of Medica Venture Partners since November 2005. Mr. Waizer joined the Medica team in 2005. Before joining Medica, he completed more than 60 initial portfolio investments, approximately 150 investment rounds (initial and follow-on) and three mergers and acquisitions and IPOs. Previously, Mr. Waizer served as the Chief Financial Officer and Chief Operating Officer of Cedar Fund and of Cedar Financial Advisors ... Inc. Prior to that, Mr. Waizer was the Chief Financial Officer at Star Ventures. Prior to that, Mr. Waizer was a Senior Audit Manager at the Israeli affiliate of Deloitte & Touche. He was also an Audit Manager at Almagor & Co., where he focused on Israeli high technology companies traded on United States stock exchanges. He has been a Director of InterCure Ltd since 2012. Mr. Waizer has been Director at Microbot Medical Inc. since May 2015. He has over 15 years of experience since 1994 in managing finance and operations in Israeli and multi-national venture capital firms. He specializes in senior financial and business research analysis. Mr. Waizer holds an M.B.A. degree in Information Systems and a B.Sc. degree in Accounting and Statistics, both from the Tel-Aviv University.Read Full Background




Corporate Headquarters
4 HaSadnaot StreetHerzliya, -- 46728IsraelPhone: 972 9 960 1900Fax: 972 9 954 2266
Board Members Memberships
2012-PresentDirectorInterCure Ltd.2015-PresentDirectorMicrobot Medical Inc.
Education
BS Tel Aviv UniversityMBA Tel Aviv University
Other Affiliations
Cedar FundCedar Financial Advisors Inc.Tel Aviv UniversityPoalim Medica IIIInterCure Ltd.Microbot Medical Inc.


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Medica Venture Partners, please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close


























Microbot Medical Inc: NASDAQ:MBOT quotes & news - Google FinanceCookies help us deliver our services. By using our services, you agree to our use of cookiesLearn moreGot itMy AccountSearchMapsYouTubePlayNewsGmailDriveCalendarGoogle+TranslatePhotosMoreShoppingWalletFinanceDocsBooksBloggerContactsHangoutsKeepEven more from GoogleSign inHidden fieldsSearch FinanceAdobe Flash Player is required for interactive charts. AllowFinanceMicrobot Medical Inc(NASDAQ:MBOT)Add to portfolioCompanySummaryNewsRelated companiesHistorical pricesFinancialsMarketsNewsPortfoliosStock screenerGoogle Domestic TrendsRecent Quotes (30 days)You have no recent quoteschg | %




Microbot Medical Inc  (Public, NASDAQ:MBOT)  
Watch this stock
 




















1.30


+0.08
(6.56%)





Jul 28 - Close


NASDAQ
real-time data -
Disclaimer

Currency in USD







Range

1.21 - 1.34



52 week

1.07 - 26.91



Open

1.25



Vol / Avg.

1.51M/919,820.00



Mkt cap

39.31M



P/E

    -



Div/yield

    -



EPS

-0.71



Shares

28.38M



Beta

-0.38



Inst. own

11%
































News





Relevance



Date











All news for Microbot Medical Inc »

Subscribe






Advertisement


Key stats and ratios




Q1 (Mar '17)
2016


Net profit margin
-
-

Operating margin
-
-

EBITD margin
-
-

Return on average assets
-115.92%
-495.92%

Return on average equity
-159.22%
-945.04%

Employees
6
-

CDP Score
-

-



Address
175 Derby St # 27/1HINGHAM, MA 02043-4007United States
- Map+1-908-9385561 (Phone)+1-302-6555049 (Fax)

Website links


http://www.microbotmedical.com/



External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters















Settings |
Technicals |



Link to this view



Volume delayed by 15 mins.Prices are not from all markets.

Sources include SIX.




















Advertisement







Related companies





Show:


Most Recent Quarter


Most Recent Annual




Add or remove columns
Save changes
Cancel







Sector: Healthcare > Industry: Bio Therapeutic Drugs

More from FactSet »










Description




Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures. Its ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company's TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.


More from Reuters »








Officers and directors





Harel Gadot

Chairman of the Board, President, Chief Executive Officer






Bio & Compensation
 - Reuters

David Ben Naim

Chief Financial Officer





Age: 48

Bio & Compensation
 - Reuters

Yehezkel Himelfarb

Chief Operating Officer, General Manager - Israeli Operations





Age: 59

Bio & Compensation
 - Reuters

Yoseph Bornstein

Director






Bio & Compensation
 - Reuters

Scott R. Burell

Director





Age: 51

Bio & Compensation
 - Reuters

Solomon Mayer

Director





Age: 62

Bio & Compensation
 - Reuters

Moshe Shoham

Director





Age: 65

Bio & Compensation
 - Reuters

Yoav Zvi Waizer

Director






Bio & Compensation
 - Reuters



Full list on Reuters »








Google Finance Beta available in: Hong Kong - Canada - U.S. - China - U.K.Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.To see all exchange delays, please  see disclaimer.©2017 Google - Google Home - Blog - Help - Report a Problem - Privacy Policy - Terms of Service



Yoav Zvi  Waizer - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Yoav Zvi  Waizer
Check out list of companies and businesses related to Yoav Zvi  Waizer. Find out Yoav Zvi  Waizer address and contact details. View other people related to Yoav Zvi  Waizer - coworkers, colleagues, companions, etc.
Address:   

C/O MICROBOT MEDICAL INC. 5 HAMADA STREET YOKNEAM 20692 Israel




Companies related to Yoav Zvi  Waizer
CIKCompany NamePositionCompany Address0000883975Microbot Medical Inc.175 DERBY ST. 27/1 . HINGHAM 02043




Yoav Zvi  Waizer on the Web
Persons related to Yoav Zvi  Waizer - Microbot Medical Inc.NamePositionCityCAPITAL AKTIENGESELLSCHAFT  ALPHA10% Owner VADUZ LIECHTENSTEINAvram  BerksonWIEN KRUMMBAUMGASSESandra  BerksonWIEN KRUMMBAUMGASSEERIC  BJERKHOLTDirector PALO ALTOERIC  BJERKHOLTDirector NEWARKYoseph  BornsteinYOKNEAMScott R  BurellMUKILTEO,STEWART  CRAIGSVP, Development & Operations PALO ALTOSTEWART  CRAIGSVP, Development & Operations NEWARKNaim  DavidHolonHarel  GadotYOKNEAMR SCOTT  GREERDirector R SCOTT  GREERDirector PALO ALTOGadot  HarelHinghamYehezkel  HimelfarbYOKNEAMGEORGE  KOSHY PALO ALTOGEORGE  KOSHY NEWARKRICARDO B  LEVYDirector RICARDO B  LEVYDirector NEWARKRICARDO B  LEVYDirector PALO ALTOLeon  Lewkowicz10% Owner YOKNEAMJudi R  LumCFO PALO ALTOMartin J.  MaddenHINGHAMIan J  MasseyChief Executive Officer VANCOUVERMARTIN M  MCGLYNNPresident & CEO PALO ALTOMARTIN M  MCGLYNNPresident & CEO NEWARKShoham  MosheHoshaya M.P. HamovilDavid Ben  NaimYOKNEAMDESMOND H  OCONNELL JRDirector PALO ALTOROGER M  PERLMUTTERDirector PALO ALTOROGER M  PERLMUTTERDirector NEWARKEliseo Oreste  SalinasEVP and Head of R&D NEWARKGREGORY T  SCHIFFMANChief Financial Officer NEWARKGREOGRY T  SCHIFFMANChief Financial Officer MOUNTAIN VIEWJOHN J  SCHWARTZDirector PALO ALTOJOHN J  SCHWARTZDirector NEWARKBurell  ScottIrvineMoshe  ShohamYOKNEAMMayer  SolomonYOKNEAMMayer  SolomonBrooklynKenneth Blair  StrattonGeneral Counsel PALO ALTOKenneth Blair  StrattonGeneral Counsel NEWARKAlan O  TrounsonDirector NEWARKANN  TSUKAMOTOEVP, Research and Development PALO ALTOANN  TSUKAMOTOEVP, Research and Development NEWARKYoav Zvi  WaizerYOKNEAMIRVING  WEISSMANDirector PALO ALTOIRVING  WEISSMANDirector NEWARKHimelfarb  YehezkelTel-AvivWaizer  YoavRa'ananaBornstein  YosephRosh-HaayinRodney KB  YoungCFO PALO ALTORodney KB  YoungCFO NEWARK












 






    Yoav Waizer | | ZoomInfo.com

Yoav Zvi Waizer: Executive Profile & Biography - Bloomberg









































  





















































































July 29, 2017 1:54 AM ET
Capital Markets

Company Overview of Medica Venture Partners



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Yoav Zvi Waizer  Partner and Chief Financial Officer, Medica Venture PartnersAgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.See Board Relationships51--
Background

		Mr. Yoav Zvi Waizer is a Partner and Chief Executive Officer of Medica Venture Partners since November 2005. Mr. Waizer joined the Medica team in 2005. Before joining Medica, he completed more than 60 initial portfolio investments, approximately 150 investment rounds (initial and follow-on) and three mergers and acquisitions and IPOs. Previously, Mr. Waizer served as the Chief Financial Officer and Chief Operating Officer of Cedar Fund and of Cedar Financial Advisors ... Inc. Prior to that, Mr. Waizer was the Chief Financial Officer at Star Ventures. Prior to that, Mr. Waizer was a Senior Audit Manager at the Israeli affiliate of Deloitte & Touche. He was also an Audit Manager at Almagor & Co., where he focused on Israeli high technology companies traded on United States stock exchanges. He has been a Director of InterCure Ltd since 2012. Mr. Waizer has been Director at Microbot Medical Inc. since May 2015. He has over 15 years of experience since 1994 in managing finance and operations in Israeli and multi-national venture capital firms. He specializes in senior financial and business research analysis. Mr. Waizer holds an M.B.A. degree in Information Systems and a B.Sc. degree in Accounting and Statistics, both from the Tel-Aviv University.Read Full Background




Corporate Headquarters
4 HaSadnaot StreetHerzliya, -- 46728IsraelPhone: 972 9 960 1900Fax: 972 9 954 2266
Board Members Memberships
2012-PresentDirectorInterCure Ltd.2015-PresentDirectorMicrobot Medical Inc.
Education
BS Tel Aviv UniversityMBA Tel Aviv University
Other Affiliations
Cedar FundCedar Financial Advisors Inc.Tel Aviv UniversityPoalim Medica IIIInterCure Ltd.Microbot Medical Inc.


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Medica Venture Partners, please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




































Waizer Yoav Zvi - StemCells Insider Transactions | TipRanks   





Go ProLogin / Sign Up Follow✓Get Real Time TransactionsInsider DetailsWaizer Yoav ZviStemCells (DEL_STEM)Director Not RankedWaizer Yoav Zvi's PerformanceWaizer Yoav Zvi has not reported any informative transactions and therefore cannot be ranked.How are Insiders Ranked? Waizer Yoav Zvi's Trading Historybased on Form 4 Follow✓Get Real Time TransactionsCompany NameInsider PositionHolding ValueLast TransactionLast Transaction  AmountLast Transaction DateDEL_STEMStemCells--Waizer Yoav Zvi has not reported any informative transactions for DEL_STEM, therefore, performance cannot be measured.See All Insider Trading from Today >You May Also LikeMeet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.Related LinksHow can I benefit from Insider Trading? >See the Top 25 Corporate Insiders >Go to Hot Stocks by Insiders >Find which stocks Insiders traded today >Become a TipRanks MemberGet the best Investing Tips & Hacks straight to your emailFree MembershipSubmitInsider Trading Daily NewsletterProfessional day-trading strategy based on predictive insider transactionsAnnual Return: +85.42%Learn More >Powered by

























Microbot Medical Inc (MBOT.OQ)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Microbot Medical Inc (MBOT.OQ)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				MBOT.OQ on NASDAQ Stock Exchange Capital Market


				1.30USD
28 Jul 2017





				    Change	(% chg)


		    
						    $0.08


					            (+6.56%)
					        






Prev Close

$1.22


Open

$1.25




Day's High

$1.34


Day's Low

$1.21




Volume

183,847


Avg. Vol

103,683




52-wk High

$26.91


52-wk Low

$1.08











					Summary





Name
Age
Since
Current Position




							Harel Gadot


2016

                                Chairman of the Board, President, Chief Executive Officer




							David Ben Naim

48
2016

                                Chief Financial Officer




							Yehezkel Himelfarb

59
2016

                                Chief Operating Officer, General Manager - Israeli Operations




							Yoseph Bornstein


2016

                                Director




							Scott Burell

51
2016

                                Director




							Solomon Mayer

62
2016

                                Director




							Moshe Shoham

65
2016

                                Director




							Yoav Waizer


2016

                                Director




							Martin Madden

56
2017

                                Independent Director



» Insider Trading





					Biographies





Name
Description




							Harel Gadot


					
							Mr. Harel Gadot serves as Chairman of the Board, President, Chief Executive Officer of the Company. He is a co-founder of Microbot Israel and has served as Chief Executive Officer since Microbot Israel was founded in November 2010. He has been the Chairman of Microbot Israel’s Board of Directors since July 2014. He also serves as the Chairman of XACT Robotics Ltd. since August 2013 and MEDX Xelerator LP since July 2016. From December 2007 to April 2010 Mr. Gadot was a Worldwide Group Marketing Director at Ethicon Inc., a Johnson and Johnson Company, where he was responsible for the global strategic marketing of the company. Mr. Gadot also held management positions, as well as leading regional strategic position for Europe, Middle-East and Africa, as well as in Israel, while at Johnson and Johnson. Mr. Gadot served as director for ConTIPI Ltd. from August 2010 until November 2013 when ConTIPI Ltd. was acquired by Kimberly-Clark Corporation. Mr. Gadot holds a B.Sc.in Business from Siena College, Loudonville NY, and an M.B.A. from the University of Manchester, UK.




							David Ben Naim


					
							Mr. David Ben Naim serves as Chief Financial Officer of the Company. He is the general manager of DBN Finance Services Ltd., a company which provides outsourcing financial services to public and private companies, since 2014. Through DBN Finance Services, Mr. Ben Naim has acted as the outsourced CFO for Emerald Medical Applications Corp. (OTC:MRLA), a digital health startup company engaged in the development, sale and service of imaging solutions, and Tempramed Inc., a private medical device company. Prior to that, Mr. Ben Naim served as Chief Financial Officer for several companies in the biomedical and technology industries. From July 2012 to September 2014, Mr. Ben Naim served as Chief Financial Officer for Insuline Medical Ltd. (TASE: INSL), an Israel-based company focused on improving performance of insulin treatment methods. From 2008 until 2011, Mr. Ben Naim served as Chief Financial Officer of Crow Technologies 1977 Ltd. (OTC:CRWTF), a company that designs, develops, manufactures and sells a broad range of security and alarm systems. From 2007 to 2008, Mr. Ben Naim served as Chief Financial Officer of Ilex Medical Ltd. (TASE:ILX), a leading company in the medical diagnostics field. From 2003 to 2007, Mr. Ben Naim was the Corporate Controller of Tadiran Telecom Ltd. He started his career in 1998 at Deloitte & Touche where he left in 2003 as an Audit Senior Manager. Mr. Ben Naim holds a B.A. in social sciences from Open University, Israel, a CPA license from Ramat Gan College, Israel, and an M.B.A. from Ono Academic College, Israel.




							Yehezkel Himelfarb


					
							Mr. Yehezkel Himelfarb serves as Chief Operating Officer, General Manager - Israeli Operations of the Company. Mr. Himelfarb was the Chief Executive Officer from 2008 through November 2016 and a member of the board of directors from 2008 through August 2016 of IceCure Medical Ltd., Tel Aviv Stock Exchange listed company that develops advanced cryotherapy systems (cryoablation) intended for the growing physician-office market. Prior to that, from 1999 to 2008, Mr. Himelfarb was the President, Chief Executive Officer and a member of the board of directors of Remon Medical Technologies, Inc., a venture backed US/Israeli company that developed and commercialized smart, miniature implants which enabled physicians to assess and treat a variety of medical conditions, where he, among other things, led its acquisition by Boston Scientific. From 1996 to 1999, he was the Vice President and Chief Operating Officer of Medtronic-InStent (Israel), which was part of Medtronic’s vascular division. From 1982 to 1996, Mr. Himelfarb had various positions at Scitex Corporation Ltd., which was an Israeli-based company specializing in specialty equipment production. Mr. Himelfarb holds a B.Sc. in Electronic Engineering and an M.B.A. in Marketing and Engineering Management, both from Tel Aviv University.




							Yoseph Bornstein


					
							Mr. Yoseph Bornstein serves as Director of the Company. He is a co-founder of Microbot Israel and has been a member of the Board of Directors since Microbot Israel was founded in November 2010. Mr. Bornstein founded Shizim Ltd., a life science holding group in October 2000 and has served as its president since then. Mr. Bornstein is the Chairman of GCP Clinical Studies Ltd., a provider of clinical research services and educational programs in Israel since January 2002. He is the Chairman of Biotis Ltd., a service company for the bio-pharmaceutical industry, since June 2000. In addition, he is the Chairman of Dolphin Medical Ltd., a service company for the medical device industry, since April 2012 and the Chairman of ASIS Enterprises B.B.G. Ltd., a business August 2007. In October 1992, Mr. Bornstein founded Pharmateam Ltd., an Israeli company that specialized in representing international pharmaceutical companies which was sold in 2000. Mr. Bornstein is also a founder of a number of other privately held life-science companies. Mr. Bornstein served as the Biotechnology Committee Chairman of the Unites States-Israel Science & Technology Commission (the “USISTF”) from September 2002 to February 2005 as well as a consultant for USISTF from September 2002 to February 2005. He is also the founder of ILSI-Israel Life Science Industry Organization and ITTN-Israel Tech Transfer Organization.




							Scott Burell


					
							Mr. Scott R. Burell serves as Director of the Company. He has served as a member of the Board of Directors of Microbot Israel since the closing of the Merger on November 28, 2016. He is the Chief Financial Officer, Secretary and Treasurer of CombiMatrix Corporation, a family health-focused clinical molecular diagnostic laboratory specializing in pre-implantation genetic screening, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders, since November 2006. He successfully led the split-off of CombiMatrix in 2007 from its former parent, has led several successful public and private debt and equity financing transactions as well as CombiMatrix’s reorganization in 2010. Prior to this, Mr. Burell had served as CombiMatrix’s Vice President of Finance since November 2001 and as its Controller from February 2001 to November 2001. From May 1999 to first joining CombiMatrix in February 2001, Mr. Burell was the Controller for Network Commerce, Inc., a publicly traded technology and information infrastructure company located in Seattle. Prior to this, Mr. Burell spent 9 years with Arthur Andersen’s Audit and Business Advisory practice in Seattle. During his tenure in public accounting, Mr. Burell worked with many clients, both public and private, in the high-tech and healthcare markets, and was involved in numerous public offerings, spin-offs, mergers and acquisitions. Mr. Burell obtained his Washington state CPA license in 1992 and is a certified public accountant (currently inactive). He holds Bachelor of Science degrees in Accounting and Business Finance from Central Washington University.




							Solomon Mayer


					
							Mr. Solomon Mayer serves as Director of the Company. He has served as a member of the Board of Directors of Microbot Israel since June 2014, as the designated director of Alpha Capital. Mr. Mayer has served as the President and Chief Executive Officer of Mooney Aviation Company since June 1999. He also serves as President of Chailife Line, an organization devoted to help restore normalcy to family life and better enable them to withstand the crises and challenges of serious pediatric illness. In addition, Mr. Mayer serves as a Director of the Laniado Hospital, International Medical Search Co. of New York, Blastgard International, Inc. and Ironwood Gold Corp.




							Moshe Shoham


					
							Dr. Moshe Shoham, D.Sc., serves as Director of the Company. He is a co-founder of Microbot Israel and has served as Chairman of Microbot Israel’s Scientific Advisor Board and as a Director since Microbot Israel was founded in November 2010. Prof. Shoham has been the head of the robotics laboratory at the Technion-Israel Institute of Technology, Department of Mechanical Engineering since October 1990 and has been a professor in the Department of Mechanical Engineering at the Technion-Israel Institute of Technology since October 1989. Prior to that, Dr. Shoham was the director of the robotic laboratory in the Department of Mechanical Engineering at Columbia University from September 1986 to September 1989. Dr. Shoham has served as a foreign member of the National Academy of Engineering in the United States since October 2014. In addition, Dr. Shoham founded Mazor Surgical Technologies Ltd., a publically traded medical device company in the field of surgical robotics, and has been its Chief Technology Officer since January 2003. Dr. Shoham earned B.Sc. in 1978, a M.Sc. in 1982 and a D.Sc. in 1986 from the Technion-Israel Institute of Technology.




							Yoav Waizer


					
							Mr. Yoav Zvi Waizer serves as Director of the Company. He has served as a member of the Board of Directors of Microbot Israel since May 2015. Mr. Waizer is a Partner and Chief Executive Officer of Medica Venture Partners, a healthcare dedicated venture investing out of Israel in innovative capital-starved early stage and special situation companies, since November 2005. Prior to his Tenure at Medica, Mr. Waizer served as CFO & COO at Cedar Fund, a venture capital fund focuses on investing in Israel-related high-tech companies in the telecom, networking, Internet-infrastructure and enterprise software areas and prior to that Mr. Waizer was the CFO of Star Ventures Israel, the Israeli fund of Star Ventures, a $1 billion venture capital fund investing in all stages of development within the Telecom, Enterprise S/W, Wireless and Life Sciences sectors. Mr. Waizer is currently a director of InterCure Ltd., a company focused on investing in medical technology companies that is traded on the Tel Aviv Stock exchange. Mr. Waizer holds Master of Business Administration in Information Systems and B.Sc. in Accounting and Statistics, both from the Tel-Aviv University.




							Martin Madden


					
							Mr. Martin J. Madden serves as Independent Director of the Company. Mr. Madden has held various positions at Johnson & Johnson and its affiliates from 1986 to January 2017, most recently as Vice President, Research & Development of DePuy Synthes, a Johnson & Johnson Company, from February 2016 to January 2017. Prior to that, from July 2015 to February 2016, Mr. Madden was the Vice President, New Product Development of Johnson & Johnson Medical Devices. From January 2012 to July 2015, Mr. Madden was the Vice President, Research & Development of Johnson & Johnson’s Global Surgery Group. Mr. Madden holds a MBA from Columbia University, a M.S. from Carnegie Mellon University in Mechanical Engineering, and a B.S. from the University of Dayton in Mechanical Engineering.











					Basic Compensation





Name
Fiscal Year Total




							Harel Gadot

--




							David Ben Naim

--




							Yehezkel Himelfarb

--




							Yoseph Bornstein

--




							Scott Burell

--




							Solomon Mayer

--




							Moshe Shoham

--




							Yoav Waizer

--




							Martin Madden

--



As Of 






					Options Compensation





Name
Options
Value




							Harel Gadot

0
0




							David Ben Naim

0
0




							Yehezkel Himelfarb

0
0




							Yoseph Bornstein

0
0




							Scott Burell

0
0




							Solomon Mayer

0
0




							Moshe Shoham

0
0




							Yoav Waizer

0
0




							Martin Madden

0
0









					Insider Trading












Name
Shares Traded
Price


Lewkowicz (Leon)
71,224
$1.67


Alpha Capital Anstalt
9,753,549
$0.00


Alpha Capital Anstalt
7,977,092
$0.00


Stratton (Kenneth Blair J.D.)
5,834
$2.92


Koshy George
2,084
$2.92


Weissman (Irving L)
48,077
$0.00


Schiffman (Gregory T)
720,000
$0.00


Massey (Ian J)
378,460
$0.00


Schiffman (Gregory T)
166,000
$0.30


Stratton (Kenneth Blair J.D.)
14,228
$0.35


Koshy George
4,378
$0.35


Massey (Ian J)
1,250,000
$0.00


Koshy George
28,457
$0.38


Stratton (Kenneth Blair J.D.)
35,024
$0.38


Schiffman (Gregory T)
25,976
$0.38


McGlynn (Martin M)
236,736
$0.38


Weissman (Irving L)
29,762
$0.00


Weissman (Irving L)
146,342
$0.00


Schwartz (John J)
146,342
$0.00


Bjerkholt (Eric H)
146,342
$0.00


Levy (Ricardo B)
146,342
$0.00


Trounson (Alan O)
146,342
$0.00


Schiffman (Gregory T)
38,307
$0.42


Greer (R Scott)
146,342
$0.00


Stratton (Kenneth Blair J.D.)
104,549
$0.45




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research




















